Bafna Pharmaceuticals

quarterly
yearly
ParticularsSep '18Jun '19Sep '19
Revenue8.817.1512.16
Expenses10.0310.8612.70
EBITDA0.15-2.560.21
EBIT-0.60-3.58-0.51
Profit Before Tax-1.23-3.71-0.55
Net Profit-1.28-2.13-0.59
Financial Ratios
Operating Profit Margin1.70%-37.52%1.90%
Net Profit Margin-14.48%-31.09%-5.10%
Earning Per Share (Diluted)-0.80-0.90-0.25
Dividends Per Share0.000.000.00